Hsu Min specialises in patents in the fields of chemistry, material science and pharmaceuticals. Her experience includes drafting and prosecuting patent applications in a wide range of technologies, including those relating to pharmaceuticals, catalytic processes, household products, electrochemistry, medical devices and polymers.
Hsu Min has a wealth of experience in European Oppositions and Appeals and regularly represents clients at Oral proceedings at the European Patent Office. She manages substantial patent portfolios and regularly provides clients with opinions on their freedom-to-operate in the light of third party rights. She works for a variety of clients including universities, start-ups and multi-national corporations.
Hsu Min has a First Class Masters’ Degree in Chemistry from Oxford University. She started in the patent profession in private practice in 1996, before joining the in-house patent department of a FTSE 100 multinational Oil & Gas company. She joined HGF as a Partner in 2011, having been a Partner at another major patent firm.
First Class Masters' Degree in Chemistry (University of Oxford)
May 10th 2022
September 21st 2020
Hsu Min has given seminars about various aspects of intellectual property to students and academics at her local university. For example, she has presented at Fellowship Programmes for Entrepreneurs.
The European Patent Office (EPO) has announced that revised Official Fees will apply to payments made on or after Monday 1st April 2024. The majority of fees will increase by …Read article
HGF are proud Event Partners of CAR-TCR Europe, which is due to go ahead from 27th – 29th February at ExCeL, Royal Victoria Dock in London. This is the European hub …Event details
Porter’s Five Forces model  is just one example of a convenient model for exploring and understanding the forces at play in a competitive marketplace. Michael Porter’s Five Forces model …Read article
In an unprecedented move, the MHRA has approved a CRISPR gene editing therapy ‘Casgevy’ for the treatment of sickle cell disease and beta-thalassaemia in patients with recurrent vaso-occlusive crises. The Casgevy …Read article
HGF is pleased to invite you to our upcoming German-language seminar on “Invention and patent searches in public databases” in Salzburg and Dresden. The seminar will showcase how public databases …Event details
“Medical devices and bioinformatics / AI diagnostic feedback – law and practice in Europe and Japan” The EPC does not allow ‘medical use’ claims for medial devices. So how do …Event details
A patent is a legal right that enables the patent holder to prevent others from making and using their invention in the country where the patent is granted. To many …Read article
Order of the classifications listed on the front of a patent and why it matters? On 1 June 2023, ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE lodged a statement of revocation of …Read article
If you would like to discuss how HGF could help you, contact one of our IP specialists.